NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

Durham-based Eboo Pharmaceuticals Inc. (EPI) is one of three U.S. biopharmaceutical companies selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) for its Partnering Program.

 

Weekly Grant Funding Opportunities

Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org).  Grant funding requests are included our regular research and include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails.  We would love to hear of their successes!

Three young bioscience companies started with funding and other help from the North Carolina Biotechnology Center wowed the crowd at today’s opening of the 2014 CED Life Science Conference in Raleigh.

Three young bioscience companies started with funding and other help from the North Carolina Biotechnology Center will be presenters at the Innovation Showcase Feb. 26 during the 2014 CED Life Science Conference in Raleigh.

The North Carolina Biotechnology Center will be closed Wednesday, Feb. 12, and Thursday, Feb. 13, due to inclement weather. Our hours on Valentine's Day, Friday, Feb. 14, will depend on conditions at that time.

The 2nd Annual Exchanging Ideas Summit will be held at NC Biotech headquarters on Wednesday, March 26, from 3:30 to 7:30 p.m. This event will highlight the importance of scientific community by bringing together scientists and community leaders from a wide variety of life science backgrounds for an evening of stimulating presentations and networking.

BIO briefs with names making news

  • Sean Kimbro, Ph.D., director of the North Carolina Central University Julius L.

In this blog post, Dennis Burns of TCG LLC looks at North Carolina's competitiveness for European business.

Eli Lilly and Durham gene editing innovator Precision Biosciences announced a research collaboration and exclusive license agreement that could potentially be worth over $2.7 billion.
Kimberly Smith, M.D., MPH, SVP and head of research and development of ViiV Healthcare in RTP, is hailed as one of the top 20 among 2020’s "Fiercest Women in Life Sciences."
IPM Chirana, a global company that makes ventilators to treat critical care patients, has selected Research Triangle Park as the site of its U.S. headquarters.
Morrisville-based Locus Biosciences has signed an agreement with a global non-profit to help fund a new CRISPR Cas3 antibacterial therapy to treat recurrent urinary tract infections.

North Carolina’s life science sector registered another year of robust growth in 2016 with deals that will create capital ​investment and high-paying jobs well into the future. Here are some of the year's highlights.

The North Carolina Biotechnology Center has been expanding its support for marine biotechnology during the past decade, and it’s proving to be a great investment for the state.

Despite some consumer resistance to genetic engineering, not all food technology innovations discussed at the North Carolina Biotechnology Center’s AgBiotech Summit 2016 engender social fears.

scroll back to top of page